Purpose: To investigate the population-based prevalence of keratoconus in US individuals aged 65 years and older.
L
ittle is known about the prevalence of keratoconus in the US elderly population. Only 1 US population-based analysis of keratoconus has been previously published, providing minimal information on aged individuals. 1 Previous studies have used Medicare claims data to estimate the incidence and prevalence of ophthalmic disease in the elderly. [2] [3] [4] In this study, we examined Medicare claims records to estimate the prevalence of keratoconus in the US elderly population.
METHODS
A multiyear cross-sectional study design was employed. The study population was based on a 5% national sample of fee-for-service Medicare beneficiaries 65 years and older from 1999 to 2003, as found in the Centers for Medicare and Medicaid Services (CMS) 5% Part B Physician/Supplier Files. These annual files contain all claims submitted nationally by physicians and limited-license practitioners for inpatient and outpatient services, and claims from freestanding ambulatory surgical centers. The 5% sample was obtained from CMS, which makes this information available for research purposes.
Beneficiaries included in the study were those having Medicare fee-for-service (Part B) coverage for at least part of a given calendar year. Beneficiaries who were enrolled in Medicare health maintenance organizations or other Medicare managed care plans for the entire calendar year were excluded from that year's calculations, as service usage data for these individuals are not reported to CMS. Medicare railroad beneficiaries were also excluded. 5 Claims files were queried for ICD-9 codes specific to keratoconus (371.6, 371.60, 371.61, and 371.62) on a calendar year basis. A keratoconus case was defined as a beneficiary having 1 or more claims with keratoconus within the calendar year. Numerators were the total number of beneficiaries receiving keratoconus care within the particular year. Denominators were beneficiary person-years with Medicare coverage-representing adjustments to the actual number of beneficiaries to reflect duration of active fee-for-service Part B enrollment. Rates were calculated on a calendar year basis. Stratification of rates by demographics was performed.
RESULTS
The number of individuals receiving keratoconus care rose steadily from 15.7/100,000 Medicare Part B beneficiary person-years in 1999 to 18.5/100,000 in 2003. The average across the 5 years of the study was 17.5/100,000 ( Table 1) . The rate declined with increasing age in all years of the study, averaging 25.4/100,000 in beneficiaries aged 65-69 years old and dropping to 7.8/100,000 in beneficiaries aged 85 years and older (Fig. 1) . Keratoconous rates did not differ by gender, but whites had a higher rate of the disease versus blacks and other races in all years of the study (Table 2) .
CONCLUSIONS
Keratoconus has typically been considered a disease of youth, with an onset typically in the second or third decade of life and progression through middle age. The disease is uncommonly seen in elderly subjects. 6 The sole US population-based estimate of keratoconus to date supports its rarity in the elderly. In the report by Kennedy et al 1 conducted in Olmsted County, Minnesota, a yearly prevalence of 55/100,000 was estimated for all ages. Only 1 individual of the 64 cases of keratoconus studied, however, was aged 65 years or older. As such, little is known about the prevalence of this disease in the elderly.
Though the differences in denominators and study design of the current study versus those of Kennedy et al do not allow for direct comparison of the respective data, this analysis, which is the first population-based estimate of keratoconus prevalence in the US elderly population, suggests that keratoconus is indeed rare among the aged, affecting approximately 18/100,000 such persons in a given year. These data also suggest that even among aged individuals, prevalence declines steadily with age.
Keratoconus is reported to affect all racial groups.
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Though an increased incidence in persons of Pakistani ethnicity versus whites has been reported from a single center in the United Kingdom, 10 we are unaware of any other analysis suggesting a racial predominance of this disease. As such, our finding of increased prevalence of keratoconus claims care in elderly white Medicare beneficiaries versus blacks or other races is notable.
This analysis has several limitations. Primarily, Medicare claims data are designed for billing purposes, not research. Also, for several reasons, this analysis likely represents an underestimate of the true prevalence of keratoconus in the US elderly population. Individuals with keratoconus but without a claim in a particular year would not be included in the rate for that year in this analysis. This may have occurred in several ways. First, cases of keratoconus diagnosed outside the Medicare system would not be captured by an analysis using Medicare data alone. Also, it is possible that significant number of elderly individuals with keratoconus in the Medicare population during the time of the analysis had developed stable disease managed with glasses or contact lenses. As these therapies are not routinely covered by the Medicare program, provider visits and claims for these services would also not be captured. Furthermore, patients who had previously undergone corneal transplantation for their keratoconus may no longer have been coded by eye providers as having keratoconus, also leading to an underestimation of prevalence using claims records. Last, as other eye problems are accumulated with age, the diagnosis of keratoconus, especially if a stable condition for the patient, may not be coded by the provider on each visit as more acute eye problems, such as diabetic retinopathy or glaucoma, are addressed and coded. This coding preference by providers for more acute eye problems may also help explain our findings of increased prevalence in whites versus blacks and other races. As blacks and other races, such as Hispanics, may have a higher prevalence of chronic eye diseases such as glaucoma and diabetes versus whites, 11, 12 they may have their visits preferentially coded for these more acute conditions rather than stable, underlying keratoconus. Last, it is possible that the rate increase over the 5-year period we observed was due to increasingly more frequent eye care visits within the existing keratoconus population.
In summary, in this analysis, we provide the first population-based estimate of keratoconus prevalence in the US Medicare population. These data support the belief that this disease is uncommon in the elderly. Analysis of Medicare claims data, though limited in some respects, may provide a useful tool for monitoring uncommon diseases, such as keratoconus, in the elderly population. 
